Literature DB >> 1000128

Extra-vesicular binding of noradrenaline and guanethidine in the adrenergic neurones of the rat heart: a proposed site of action of adrenergic neurone blocking agents.

A Giachetti, R A Hollenbeck.   

Abstract

1 The binding and efflux characteristics of [14C]-guanethidine and [3H]-noradrenaline were studied in heart slices from rats which were pretreated with reserpine and nialamide. 2 Binding of both compounds occurred at extra-vesicular sites within the adrenergic neurone. After a brief period of rapid washout, the efflux of [14C]-guanethidine and [3H]-noradrenaline proceeded at a steady rate. The efflux of both compounds appeared to occur from a single intraneuronal compartment. 3 (+)-Amphetamine accelerated the efflux of [14C]-noradrenaline; this effect was inhibited by desipramine. 4 Unlabelled guanethidine and amantadine also increased the efflux of labelled compounds. Cocaine in high concentrations increased slightly the efflux of [14C]-guanethidine but not that of [3H]-noradrenaline. 5 Heart slices labelled with [3H]-noradrenaline became refractory to successive exposures to releasing agents although an appreciable amount of labelled compound was still present in in these slices. 6 It is suggested that [14C]-guanethidine and [3H]-noradrenaline are bound at a common extravesicular site within the adrenergic neurone. Binding of guanethidine to the extra-vesicular site may be relevant to its pharmacological action, i.e., the blockade of adrenergic transmission.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1000128      PMCID: PMC1667487          DOI: 10.1111/j.1476-5381.1976.tb08616.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  26 in total

1.  BLOCKING ACTION OF SYMPATHOMIMETIC AMINES ON THE UPTAKE OF TRITIATED NORADRENALINE BY MOUSE CEREBRAL CORTEX TISSUES IN VITRO.

Authors:  S B ROSS; A L RENYI
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1964

2.  The action of guanethidine with particular reference to the sympathetic nervous system.

Authors:  G F ABERCROMBIE; B N DAVIES
Journal:  Br J Pharmacol Chemother       Date:  1963-02

3.  A study of the factors affecting the aluminum oxide-trihydroxyindole procedure for the analysis of catecholamines.

Authors:  A H ANTON; D F SAYRE
Journal:  J Pharmacol Exp Ther       Date:  1962-12       Impact factor: 4.030

4.  Effect of sympathomimetic amines on the blocking action of guanethidine, bretylium and xylocholine.

Authors:  M D DAY
Journal:  Br J Pharmacol Chemother       Date:  1962-04

5.  Effects of drugs on uptake of isotopic norepinephrine by cat tissues.

Authors:  H J DENGLER; H E SPIEGEL; E O TITUS
Journal:  Nature       Date:  1961-08-19       Impact factor: 49.962

6.  A new general concept of the neurohumoral functions of acetylcholine and acetylcholinesterase.

Authors:  G B KOELLE
Journal:  J Pharm Pharmacol       Date:  1962-02       Impact factor: 3.765

7.  Effect of d-amphetamine on spontaneous and stimulation-induced release of catecholamines.

Authors:  L O Farnebo
Journal:  Acta Physiol Scand Suppl       Date:  1971

8.  On the nature of the adrenergic neuron extragranular amine binding site.

Authors:  S J Enna; P A Shore
Journal:  J Neural Transm       Date:  1974       Impact factor: 3.575

9.  Effects of choline 2:6-xylyl ether bromide upon the suprarenal medulla of the rat.

Authors:  R E COUPLAND; K A EXLEY
Journal:  Br J Pharmacol Chemother       Date:  1957-09

10.  Evidence for a competitive antagonism of guanethidine by dexamphetamine.

Authors:  M D DAY; M J RAND
Journal:  Br J Pharmacol Chemother       Date:  1963-02
View more
  9 in total

1.  Action of guanethidine on rabbit atrial membranes.

Authors:  Y Misu; H Nishio
Journal:  Br J Pharmacol       Date:  1978-05       Impact factor: 8.739

2.  Guanethidine after twenty years: a pharmacologist's perspective.

Authors:  R A Maxwell
Journal:  Br J Clin Pharmacol       Date:  1982-01       Impact factor: 4.335

3.  Uptake of 14C-tyramine and release of extravesicular 3H-noradrenaline in isolated perfused rabbit hearts.

Authors:  H Bönisch; E Rodrigues-Pereira
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-07       Impact factor: 3.000

4.  Prevention by guanethidine analogues of output of noradrenaline induced by sodium reduction in rabbit ventricular slices.

Authors:  T Hosotani; Y Misu
Journal:  Br J Pharmacol       Date:  1978-09       Impact factor: 8.739

5.  Accumulation of debrisoquine by platelets in vivo: a model of events at the peripheral adrenergic neurone.

Authors:  J H Silas; G T Tucker; A J Smith; N R Fieller
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

6.  DMPP and the adrenergic nerve terminal: mechanisms of noradrenaline release from vesicular and extravesicular compartments.

Authors:  H J Holbach; R Lindmar; K Löffelholz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1977-11       Impact factor: 3.000

7.  Studies on the mode of action of bretylium and guanethidine in post-ganglionic sympathetic nerve fibres.

Authors:  J A Brock; T C Cunnane
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1988-11       Impact factor: 3.000

8.  Comparison of the electrocortical changes induced by (+)-amphetamine and chlorpromazine when perfused directly into the dorsal raphé nucleus of the cat.

Authors:  B J Key; L Krzywosinski
Journal:  Br J Pharmacol       Date:  1978-08       Impact factor: 8.739

9.  Mechanism of uptake and retrograde axonal transport of noradrenaline in sympathetic neurons in culture: reserpine-resistant large dense-core vesicles as transport vehicles.

Authors:  M E Schwab; H Thoenen
Journal:  J Cell Biol       Date:  1983-06       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.